Indaptus Therapeutics raises about $24.0 million in private placement
Indaptus Therapeutics entered a stock purchase agreement for a private placement of 20,338,974 common shares, expected to generate about $24.0 million in gross proceeds. Shares are priced at the Nasdaq Minimum Price plus $0.015 per share, with closing subject to customary conditions.